Sanofi (SNY) Long-Term Deferred Tax (2009 - 2025)

Sanofi (SNY) has 17 years of Long-Term Deferred Tax data on file, last reported at $10.0 billion in Q4 2025.

• Quarterly Long-Term Deferred Tax rose 17.7% year-over-year to $10.0 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.0 billion (up 17.7% YoY) and the FY2025 annual result came in at $10.0 billion, up 17.7% from the prior year.
• Long-Term Deferred Tax grew to $10.0 billion in Q4 2025 per SNY's latest filing, from $9.1 billion in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $10.0 billion in Q4 2025, with the low at $5.1 billion in Q2 2021.
• Average Long-Term Deferred Tax over 5 years is $7.0 billion, with a median of $6.7 billion recorded in 2023.
• Year-over-year, Long-Term Deferred Tax slipped 4.02% in 2021 and gained 27.24% in 2023.
• Sanofi's Long-Term Deferred Tax stood at $5.3 billion in 2021, then advanced by 4.37% to $5.5 billion in 2022, then increased by 25.96% to $6.9 billion in 2023, then climbed by 23.12% to $8.5 billion in 2024, then gained by 17.7% to $10.0 billion in 2025.
• Business Quant data shows SNY's Long-Term Deferred Tax at $10.0 billion in Q4 2025, $9.1 billion in Q2 2025, and $8.5 billion in Q4 2024.